Drug recall · June 1, 2022
Daytrana recall
Why: Defective Delivery System: customer complaints exceeded respective action limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Daytrana (methylphenidate transdermal system) Delivers 10 mg over 9 hours (1.1 mg/hr) Contains: 30 Patches, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL, 33186, NDC 68968-5552-3
- Lots / codes
Lot: 90764 Exp. 08/2022
- Quantity
- 274, 110 patches
- Company
- Noven Pharmaceuticals Inc, Miami, FL
- Distribution
- Nationwide to the U.S. Market
- Initiated
- May 6, 2022 · Voluntary: Firm initiated
- Classified
- May 20, 2022
- Reported
- June 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Daytrana
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.